Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
33.98
+0.52 (1.55%)
At close: Aug 29, 2025, 4:00 PM
34.30
+0.32 (0.94%)
After-hours: Aug 29, 2025, 7:30 PM EDT
Bruker Revenue
Bruker had revenue of $797.40M in the quarter ending June 30, 2025, a decrease of -0.41%. This brings the company's revenue in the last twelve months to $3.44B, up 10.36% year-over-year. In the year 2024, Bruker had annual revenue of $3.37B with 13.56% growth.
Revenue (ttm)
$3.44B
Revenue Growth
+10.36%
P/S Ratio
1.50
Revenue / Employee
$302,106
Employees
11,396
Market Cap
5.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.37B | 401.90M | 13.56% |
Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BRKR News
- 17 days ago - Bruker: Former Academia Customer Strength, Now Incredible Weakness - Seeking Alpha
- 20 days ago - Bruker Announces Quarterly Dividend - Business Wire
- 26 days ago - Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors - Business Wire
- 27 days ago - These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 Results - Benzinga
- 27 days ago - Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - Benzinga
- 4 weeks ago - Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Bruker Reports Second Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - Business Wire